Inhibition of Tumor Cell Proliferation by Thieno[2,3‐d]pyrimidin‐4(1H)‐one‐based Analogues.

Yanong D. Wang,Steven W. Johnson,Dennis Powell,John P. McGinnis,Miriam Miranda,Sridhar K. Rabindran

DOI: https://doi.org/10.1002/chin.200604158

2006-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.

What problem does this paper attempt to address?

Inhibition of Tumor Cell Proliferation by Thieno[2,3-d]pyrimidin-4(1H)-one-based Analogues.

Yanong D. Wang,Steven Johnson,Dennis Powell,John P. McGinnis,Miriam Miranda,Sridhar K. Rabindran

DOI: https://doi.org/10.1002/chin.200604158

2006-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.
Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs

Yanong D. Wang,steven w johnson,Dennis Powell,John P. McGinnis,Miriam Miranda,Sridhar K. Rabindran

DOI: https://doi.org/10.1016/j.bmcl.2005.05.127

IF: 2.94

2006-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:The synthesis of a series of novel tricyclic thieno[2,3-d]pyrimidin-4(1H)-one-based analogs and their anti-proliferative activities are described.
Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Xiaoming Yang,Qian Shi,Yi-Nan Liu,Guiyu Zhao,Kenneth F. Bastow,Jau-Chen Lin,Shuenn-Chen Yang,Pan-Chyr Yang,Kuo-Hsiung Lee

DOI: https://doi.org/10.1021/jm9009263

IF: 8.039

2009-01-01

Journal of Medicinal Chemistry

Abstract:Nineteen new phenanthrene-based tylophorine analogues with various functional groups on the piperidine moiety were designed, synthesized, and evaluated for in vitro anticancer activity against four human tumor cell lines. Analogues 15 and 21 showed approximately 2-fold enhanced inhibitory activity as compared with our prior lead compound (PBT-1). Analogues 23 and 24 with S- and R-configured substituents, respectively, at the piperidine 3'-position exhibited comparable cytotoxicity to that of PBT-1. Furthermore, mechanistic studies to investigate the effects of the new compounds on Akt protein in lung cancer cells and the NF-kB signaling pathway suggested that the compounds may exert their inhibitory activity on tumor cells through inhibition of activation of both Akt and NF-kB signaling pathway.
Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.

Taijie Chen,Yu Luo,Youhong Hu,Bo Yang,Wei Lu

DOI: https://doi.org/10.1016/j.ejmech.2013.04.008

IF: 7.088

2013-01-01

European Journal of Medicinal Chemistry

Abstract:A series of 1,6-diaryl pyridin-2(1H)-one analogs were designed and synthesized via consecutive Chan–Lam coupling and Suzuki coupling. These novel compounds were evaluated for their antiproliferative activity against two tumor cell lines (SKOV-3 and HepG2). Compounds 1b, 1c, 1e and 1f displayed comparable in vitro cytotoxicity with taxol, while their in vivo antitumor activity was less effective than taxol. In addition, cell cycle assay indicated that these 1,6-diaryl pyridin-2(1H)-one compounds induced cell cycle arrest in the G1/M phase in the HepG2 cell line.
Parallel Synthesis and Biological Evaluation of 5,6,7,8‐tetrahydrobenzothieno[2,3‐d]pyrimidin‐4(3h)‐one Cytotoxic Agents Selective for P21‐deficient Cells.

Lee D. Jennings,Scott L. Kincaid,Yanong D. Wang,Girija Krishnamurthy,Carl F. Beyer,John P. McGinnis,Miriam Miranda,Carolyn Discafani,Sridhar K. Rabindran

DOI: https://doi.org/10.1002/chin.200605230

2006-01-01

ChemInform

Abstract:For Abstract see ChemInform Abstract in Full Text.
Synthesis And Anti-Tumor Activity Of 4-(Methoxyl Thienyl)-3-(Substituted Benzoyl) Pyrroles

Kai Zhao,Shuai Wang,Xiaoping Zhan,Zenglu Liu,Zhenmin Mao

DOI: https://doi.org/10.6023/cjoc201610044

2017-01-01

Chinese Journal of Organic Chemistry

Abstract:33 novel 4-substituted thienyl pyrrole compounds were synthesized via replacement, Vilsmeier-Hack, aldol condensation and Van Leusen pyrrole reaction using 2-methoxythiophen, 3-methoxythiophene, 3,4-dibromothiophene and substituted acetophenone as raw materials. The structures of all target compounds were characterized by 1H NMR, 13C NMR and HRMS, meanwhile the cell proliferation inhibition efficacy was estimated against CHO, HCT-116, MGC80-3, SGC-7901 and HUVEC cell lines. The results revealed that some target compounds exhibited strong (IC50 <= 20 mu mol/L) or moderate (20 mu mol/L<IC50 <= 50 mu mol/L) proliferation inhibition efficacy against tumor cells, meanwhile no significant inhibition activity on HUVEC, which indicated that these compounds had high selectivity. Herein, some compounds showed strong or moderate inhibition efficacy against MGC80-3. The IC50 values of [4-(3,4-dimethoxythiophen-2-yl)-1H-pyrrol-3-yl](4-phenylphenyl)methanone (4a-2) and [4-(3,4-dimethoxythiophen-2-yl)-1H-pyrrol-3-yl](3-bromophenyl) methanone (4a-7), were 8.6 and 8.5 mu mol/L against MGC80-3, respectively, and the IC50 value of 4a-7 was 20.0 mu mol/L against HCT-116. Both compounds 4a-2 and 4a-7 exhibited moderate inhibition efficacy against SGC-7901.
Synthesis and Anti-Tumor Activity of 1,4-Dihydrothieno[3',2':5,6]Thiopyrano[4,3-c]pyrazole-3-carboxylic Amide Derivatives

Rui Sun,Jing Song,Hui Zhao,Chun-Li Yan,Ai-Jun Zhang,Koirala Diwa,Da-Wei Li,Chun Hu

DOI: https://doi.org/10.5246/jcps.2011.01.004

2011-01-01

Journal of Chinese Pharmaceutical Sciences

Abstract:Five 1,4-dihydrothieno[3′,2′:5,6]thiopyrano[4,3-c]p5Tazole-3-carboxylic amide derivatives were synthesized from 2-mercaptothiophene via a six-step procedure. The prepared compounds were initially evaluated for their antiproliferative activity using the estrogen receptors expressing MCF-7 human mammary tumor cell line in vitro. All of the prepared compounds showed moderate anti-tumor activity.
New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Jian-Guo Yang,Fu-You Pan

DOI: https://doi.org/10.2174/157017807780414181

2007-01-01

Letters in Organic Chemistry

Abstract:Fifteen new 3-[(4-hydroxy-6-methly-2(1H)-pyridinones)-3-yl]-4-substituted- (1H)-1,2,4-triazole-5-thione compounds were synthesized from methyl 4-hydroxy-6- methyl-2-oxo-1,2-dihydropyridine-3-carboxylate in good overall yields by four step reactions. Molecular structure of these compounds was confirmed by IR, NMR, MS, elemental analysis and X-ray diffraction. Their antitumor activities were evaluated in vitro by the SRB and MTT methods. The results show that there are two compounds which are highly effective against KB cells and one compound which is highly effective against Bel-7402 cells.
3-Aryl Β-Carbolin-1-ones As a New Class of Potent Inhibitors of Tumor Cell Proliferation: Synthesis and Biological Evaluation

SZ Wang,YM Dong,XY Wang,XY Hu,JO Liu,YF Hu

DOI: https://doi.org/10.1039/b412921k

2005-01-01

Organic & Biomolecular Chemistry

Abstract:A novel three-step synthesis of 3-aryl β-carbolin-1-ones from non-indole starting materials has been developed. The two nitrogen atoms in β-carbolin-1-one were introduced efficiently by Michael addition of ethyl acetamidocyanoacetate to chalcone. The desired pyridone and indole rings were assembled by an intramolecular ketone–nitrile annulation mediated by aqueous HCl–HOAc and a Cu(I)-catalyzed intramolecular N-arylation of the amide, respectively. The target compounds were found to possess significant activity against tumor cell proliferaton.
Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents

Farhana Islam,Arpit Doshi,Andrew J. Robles,Tasdique M. Quadery,Xin Zhang,Xilin Zhou,Ernest Hamel,Susan L. Mooberry,Aleem Gangjee

DOI: https://doi.org/10.3390/molecules27010321

IF: 4.6

2022-01-05

Molecules

Abstract:A series of eleven 4-substituted 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines were designed and synthesized and their biological activities were evaluated. Synthesis involved the Gewald reaction to synthesize ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ring, and SNAr reactions. Compound 4 was 1.6- and ~7-fold more potent than the lead compound 1 in cell proliferation and microtubule depolymerization assays, respectively. Compounds 4, 5 and 7 showed the most potent antiproliferative effects (IC50 values < 40 nM), while compounds 6, 8, 10, 12 and 13 had lower antiproliferative potencies (IC50 values of 53–125 nM). Additionally, compounds 4–8, 10 and 12–13 circumvented Pgp and βIII-tubulin mediated drug resistance, mechanisms that diminish the clinical efficacy of paclitaxel (PTX). In the NCI-60 cell line panel, compound 4 exhibited an average GI50 of ~10 nM in the 40 most sensitive cell lines. Compound 4 demonstrated statistically significant antitumor effects in a murine MDA-MB-435 xenograft model.

chemistry, multidisciplinary,biochemistry & molecular biology
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy

Chengyong Wu,Lele Zhang,Zhilan Zhou,Lun Tan,Zhijia Wang,Cuiyu Guo,Yuxi Wang

DOI: https://doi.org/10.1016/j.ejmech.2024.116649

2024-10-05

Abstract:Guided by the X-ray cocrystal structure of the lead compound 4a, we developed a series of thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines demonstrating potent antiproliferative activity against four tumor cell lines. Two analogs, 13 and 25d, exhibited IC50 values around 1 nM and overcame P-glycoprotein (P-gp)-mediated multidrug resistance (MDR). At low concentrations, 13 and 25d inhibited both the colony formation of SKOV3 cells in vitro and tubulin polymerization. Furthermore, mechanistic studies showed that 13 and 25d induced G2/M phase arrest and apoptosis in SKOV3 cells, as well as dose-dependent inhibition of tumor cell migration and invasion at low concentrations. Most notably, the X-ray cocrystal structures of compounds 4a, 25a, and the optimal molecule 13 in complex with tubulin were elucidated. This study identifies thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines as representatives of colchicine-binding site inhibitors (CBSIs) with potent antiproliferative activity.
Synthesis and Evaluation of Biological Activities of Thieno-[2,3- d ]-pyrimidine Derivatives

Yue Guo,Chenglu Qian,Rongrong Yang,Zhongfei Han,Guoxiang Sun,Yaquan Sun

DOI: https://doi.org/10.21577/0103-5053.20240198

2024-11-09

Journal of the Brazilian Chemical Society

Abstract:Guo, Yue ; Qian, Chenglu ; Yang, Rongrong ; Han, Zhongfei ; Sun, Guoxiang ; Sun, Yaquan ; A series of novel thieno[2,3-d]pyrimidine derivatives were designed, synthesized and evaluated for their biological ability. 2-Amino-4,7-dihydro-5H-thieno[2,3-d]pyrano-3-cyanonitrile was synthesized by Gewald reaction using pyranone as substrate, malonitrile and sulfur powder as raw materials and triethylamine as base at room temperature. Subsequent amination with N,N-dimethylformamide dimethyl acetal (DMF-DMA) gave N'-(3-cyano-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-N,N-dimethylmethanimidamide. In this article, the 23 thieno[2,3-d] pyrimidines were obtained by Dimroth rearrangement condensation with different anilines, 16 of them being new compounds. Meanwhile, all compounds were assessed for breast cancer MDA-MB-231 cell line bioactivity with paclitaxel (PTX) as the positive control, and all compounds in the series showed inhibitory effects on breast cancer cell MDA-MB-231. The IC50 of compound l against MDA-MB-231 is 27.6 μM, which is similar to that of PTX with an IC50 of 29.3 μM. This means that compound l exhibits comparable inhibitory activity to PTX in MDA-MB-231 cells and may be considered as a potential anti-MDA-MB-231 inhibitor.

chemistry, multidisciplinary
Antitumor Activity Of A 5-Hydroxy-1h-Pyrrol-2-(5h)-One-Based Synthetic Small Molecule In Vitro And In Vivo

yunyun geng,xiaojian wang,luo yang,haili sun,yongqiang wang,yue zhao,ruiping she,meixiang wang,dexian wang,jun tang

DOI: https://doi.org/10.1371/journal.pone.0128928

IF: 3.7

2015-01-01

PLoS ONE

Abstract:Alternative chemo-reagents are in great demand because chemotherapy resistance is one of the major challenges in current cancer treatment. 5-hydoxy-1H-pyrrol-2-(5H)-one is an important N-heterocyclic scaffold that is present in natural products and medicinal chemistry. However, its antitumor activity has not been systematically explored. In this study, we screened a panel of 5-hydoxy-1H-pyrrol-2-(5H)-one derivatives and identified compound 1d as possessing strong anti-proliferative activity in multiple cancer cell lines. Cell cycle analysis revealed that 1d can induce S-phase cell cycle arrest and that HCT116 was sensitive to 1d-induced apoptosis. Further analysis indicated that 1d preferentially induced DNA damage and p53 activation in HCT116 cells and that 1d-induced apoptosis is partly dependent on p53. Furthermore, we showed that 1d significantly suppressed tumor growth in xenograft tumor models in vivo. Taken together, our results suggest that 5-hydoxy-1H-pyrrol-2-(5H)-one derivatives bear potential antitumor activity and that 1d is an effective agent for cancer treatment.
Synthesis and Antitumor Activity of a Novel Series of 6-Substituted Pyrrolo[2,3-D]pyrimidines As Potential Nonclassical Antifolates Targeting Both Thymidylate and Purine Nucleotide Biosynthesis.

Yi Liu,Chuang Zhang,Hongying Zhang,Meng Li,Jiangsong Yuan,Yurui Zhang,Jiaqi Zhou,Huicai Guo,Lijuan Zhao,Yumin Du,Lei Wang,Leiming Ren

DOI: https://doi.org/10.1016/j.ejmech.2015.01.055

IF: 7.088

2015-01-01

European Journal of Medicinal Chemistry

Abstract:A novel series of 2-amino-4-oxo-6-substituted pyrrolo[2,3-d]pyrimidines were designed and synthesized as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis. Condensation of 2,4-diamino-6-hydroxypyrimidine with ethyl-4-chloroacetoacetate and subsequent hydrolysis afforded the key intermediate, 2-amino-4-oxo-pyrrolo[2,3-d]pyrimidin-6-yl-acetic acid. Coupling with various amino acid methyl esters followed by saponification and condensation with 3(aminomethyl)pyridine provided target compounds 1-9. The new compounds exhibited micromolar to submicromolar antiproliferative potencies against a panel of tumor cell lines including KB, A549 and HepG2. Growth inhibition of compound 2 toward KB cells resulted in cytotoxicity and G1/G2-phase accumulation, and was partially protected by excess thymidine and adenosine, but was completely reversed in the combination of thymidine and adenosine, indicating both thymidylate and de novo purine nucleotide synthesis as the targeted pathway. However, 5-aminoimidazole-4-carboxamide (AICA) protection was incomplete, suggesting inhibition of both glycinamide ribonucleotide formyltransferase (GARFTase) and AICA ribonucleotide formyltransferase (AICARFTase). The results of the docking studies show that 2 could bind and inhibit both thymidylate synthase (TS) and the two folate-dependent purine biosynthetic enzymes (GARFTase and AICARFFase), which is consistent with the results of in vitro metabolic assays. Our studies establish that compound 2 is an excellent lead analog as a multitargeted antifolate for further structure optimization. (C) 2015 Elsevier Masson SAS. All rights reserved.
Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies

Irina A Gorbunova,Anna Rogova,Darya R Akhmetova,Roman Yu Sidorov,Eugene E Priakhin,Ramiz R Makhmudov,Daria A Shipilovskikh,Olga S Epifanovskaya,Alexander S Timin,Sergei A Shipilovskikh

DOI: https://doi.org/10.1016/j.bioorg.2024.107468

Abstract:A new efficient and versatile one-pot three-component synthesis of substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine derivatives has been developed. It is based on a multistep cascade reaction from 2-aminothiophenes and 2-hydroxy-4-oxobut-2-enoic acids, and derivatives of cyanoacetic acid catalyzed by diisopropylethylamine. As a result, novel pyrrolo[1,2-a]thieno[3,2-e]pyrimidine derivatives (21 compounds) were synthesized in a mild reaction conditions with a high yield. The structures of the developed compounds were confirmed by NMR and elemental analysis. The influence of electron-withdrawing or electron-donor substituents on the antitumor activity of the developed compounds has been identified. In vitro screening analysis of 21 compounds revealed six lead candidates (12aa, 12dc, 12hc, 12ic, 12lb, and 12mb) that demonstrated the most significant antitumor activity against B16-F10, 4T1 and CT26 cells. Necrosis/apoptosis assay showed that apoptosis was the predominant mechanism of cell death. Molecular docking analysis revealed several potential targets for tested compounds, i.e. phosphatidylinositol 5-phosphate 4-kinase (PI5P4K2C), proto-oncogene serine/threonine-protein kinase (Pim-1), nicotinamide phosphoribosyltransferase (NAMPT) and dihydrofolate reductase (DHFR). The lead compound (12aa) can effectively induce cell apoptosis, possesses a high yield (98 %) and requires low-cost starting chemicals for its synthesis. In vivo experiments with melanoma-bearing mice confirmed that 12aa compound resulted in the significant tumor inhibition on 15 d after the therapy. In particular, tumor volume was ∼0.19 cm3 for 50 mg/kg versus ∼2.39 cm3 in case of untreated mice and tumor weight was ∼71.6 mg for 50 mg/kg versus ∼452.4 mg when considered untreated mice. Thus, our results demonstrated the high potential of the 12aa compound in the treatment of melanoma and can be recommended for further preclinical studies.
Synthesis, photophysical properties, anticancer evaluation, and molecular docking studies of new pyrimidine linked 4‐arylidene‐thiazolidin‐4‐ones as potent anticancer agents

Rasha Jame

DOI: https://doi.org/10.1002/bio.4672

IF: 2.613

2024-01-24

Luminescence

Abstract:5‐(4‐[Dimethylamino]benzylidene)‐2‐(pyrimidin‐4‐ylimino)thiazolidin −4‐one hybrid 3c demonstrated a marked inhibition (IC50 = 9.17 ± 0.31 μM) against the MCF‐7 cell line and a robust docking score with S = −7.2694 kcal/mol through root mean square deviation 1.1667 in the molecular docking study towards PDB: 1 M17. The reaction of 4‐(chloroacetamido)pyrimidine (1) with ammonium thiocyanate gave 2‐(pyrimidin‐4‐ylimino)thiazolidin‐4‐one (2), which, when condensed with four substituted benzaldehyde analogues, gave the consequent 5‐arylidine‐2‐(pyrimidin‐4‐ylimino)thiazolidin‐4‐ones 3a–d. In addition, the absorbance and fluorescence behaviours of pyrimidinylimino‐thiazolidin‐4‐one hybrids 3a–d in various organic solvents were investigated. The emphasis was on studying UV absorption capacities and the effect of various structural components on photophysical qualities such as the 5‐arylidene‐2‐(pyrimidin‐4‐ylimino)thiazolidin‐4‐ones and N,N‐dimethylamino tail. The cytotoxic effect of four pyrimidinylimino‐thiazolidin‐4‐one hybrids 3a–d on tumour cell lines (HepG2, HCT‐116, PC3, MCF‐7) and a normal cell line (WI38) is investigated in this work. The cytotoxicity was measured by comparing the half‐maximal inhibitory concentration (IC50) to the reference medication, 5‐fluorouracil. The findings indicate that these hybrid compounds had varying cytotoxic effects on the cell lines examined; hybrids 3b and 3c demonstrated significant anticancer activity against MCF‐7 with IC50 values of 7.53 ± 0.43 and 9.17 ± 0.31 μM, respectively. The inhibitory efficacy of various synthesized hybrids on the epidermal growth factor receptor (EGFR) kinase was investigated. EGFR is a crucial target in cancer treatment because inhibiting it may reduce tumour development and proliferation. The IC50 value was used to calculate the inhibitory activity, which is the concentration of inhibitor necessary to induce half‐maximal inhibition of EGFR kinase activity. In addition, the predicted ADME results show that pyrimidinylimino‐thiazolidin‐4‐one hybrids have good pharmacokinetic properties; hybrid 3d is more lipophilic than the other compounds. It has a medium molecular weight, a small number of hydrogen bond acceptors and donors, and a large number of aromatic heavy atoms. Moreover, molecular docking simulations revealed precise information on the interactions of pyrimidinylimino‐thiazolidin‐4‐one hybrids 3a–d and 5‐Fu with their respective protein targets. These interactions point to possible pathways for their biological activities and call for more testing to establish their effectiveness as bioactive molecules or therapeutic candidates.

chemistry, analytical
Synthesis and in vitro cytotoxic evaluation of novel N -(3,4,5-trimethoxyphenyl)pyridin-2( 1H )-one derivatives

Taijie Chen,Yu Luo,Li Sheng,Jia Li,Youhong Hu,Wei Lu

DOI: https://doi.org/10.1007/s11030-013-9442-1

2013-01-01

Molecular Diversity

Abstract:series of novel N -(3,4,5-trimethoxyphenyl)pyridin-2( 1H )-one derivatives were designed, synthesized, and evaluated for their in vitro cytotoxicity against human colon cancer cells HCT-116. The key steps involved consecutive Chan–Lam- and Buchwald–Hartwig couplings. Most of these C-6 substituted pyridone derivatives showed moderate antiproliferative activity. The preliminary SAR indicated that the conformationally restricted pyridones exhibited more potent cytotoxicity than the flexible counterparts. In addition, cell cycle analysis of the selected compounds 4b and e showed a G2/M arrest, suggesting a possible antitubulin mechanism for these novel pyridone derivatives.
Identification of Thiazolo[5,4-D]pyrimidine Derivatives As Potent Antiproliferative Agents Through the Drug Repurposing Strategy

Zhong-Hua Li,Ji Zhang,Xue-Qi Liu,Peng-Fei Geng,Jin-Lian Ma,Bo Wang,Tao-Qian Zhao,Bing Zhao,Hao-Ming Wei,Chao Wang,Dong-Jun Fu,Bin Yu,Hong-Min Liu

DOI: https://doi.org/10.1016/j.ejmech.2017.04.056

IF: 7.088

2017-01-01

European Journal of Medicinal Chemistry

Abstract:A series of thiazolo[5,4-d]pyrimidine derivatives were synthesized and evaluated for their antiproliferative activities on three cancer cell lines. The structure-activity relationship studies were conducted through the variation in the three regions of the thiazolo-pyrimidine core. Substitution with morpholine led to compound 24, which exerted the most potent antiproliferative activity as well as good selectivity between cancer and normal cells (IC50 values of 1.03 μM against MGC803 and 38.95 μM against GES-1). In addition, compound 24 inhibited the colony formation and migration of MGC803 as well as induced apoptosis. Western blot experiments indicated the expression changes of apoptosis-related proteins, including up-regulation of Bax and caspase-3/9, as well as down-regulation of Bcl-2.
Rational synthesis and evaluation of 2,4-diamino-thieno[2,3-d]pyrimidines as antitumor agents

Yumeng Gao,Ainv Zhang,Li Li,Fengxu Wu,Yanggen Hu

DOI: https://doi.org/10.1016/j.jscs.2023.101794

IF: 4.712

2023-12-23

Journal of Saudi Chemical Society

Abstract:Based on structure-guided of thieno[2,3-d]pyrimidine skelecton functionalities and computer-aided drug development strategy, a series of novel 2,4-diamino-thieno[2,3-d]pyrimidine derivatives were designed and synthesized, and their structure confirmed by 1 H NMR, 13 C NMR and HR-MS. All synthesized compounds were evaluated for antitumor activities against hepatic carcinoma (HepG2) cell lines in vitro, and results showed that all the target compounds exhibited potent antitumor activity. Preliminary comparison indicated that a more bulky substituent group at the C-4 position, and at the same time the introduction of 3-Cl on the phenyl ring with 4-methyl group on the C-2 position of thieno[2,3-d]pyrimidine have remarkable influence on activity. One of the expected target compound 5i showed the best inhibition activities against HepG2 with IC 50 value 0.17μmol/L. To further investigate the structure-activity relationship, the docking experiment of 5i , 5j , 5o and Gefitinib on EGFR were performed. The docking results displayed that compound 5i was able to be tightly embedded in the active pocket of EGFR and the binding energy is most negative with EGFR, which demonstrating that compound 5i can be take a potential lead compound for further lucubrate.

chemistry, multidisciplinary
Discovery of new thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives as orally active phosphoinositide 3-kinase inhibitors

Yan Sun,Rong Fu,Songwen Lin,Jingbo Zhang,Ming Ji,Yan Zhang,Deyu Wu,Kehui Zhang,Hua Tian,Mingyi Zhang,Li Sheng,Yan Li,Jing Jin,Xiaoguang Chen,Heng Xu

DOI: https://doi.org/10.1016/j.bmc.2020.115890

2021-01-01

Abstract:As abnormal PI3K signaling is a feature of many types of cancer, the development of orally active PI3K inhibitors is of great significance for targeted cancer therapy. Through integrating strategies of reducing aromatic character/increasing the fraction of sp<a class="workspace-trigger" href="#b0015">3</a> carbons together with scaffold hopping, we designed and synthesized two new series of thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives for use as PI3K inhibitors. Our structure-activity relationship studies led to the identification of thieno[2,3-d]pyrimidine 6a and thiazolo[5,4-d]pyrimidine 7a, which exhibited remarkable nanomolar PI3K potency, good antiproliferative activity, favorable pharmacokinetic properties and significant in vivo anti-cancer efficacy. Notably, thiazolo[5,4-d]pyrimidine 7a had better anti-cancer activity and drug-like properties than thieno[2,3-d]pyrimidine 6a and is worthy of further pre-clinical evaluation for its use in cancer treatment.

biochemistry & molecular biology,chemistry, medicinal, organic

Inhibition of Tumor Cell Proliferation by Thieno[2,3‐d]pyrimidin‐4(1H)‐one‐based Analogues.

Inhibition of Tumor Cell Proliferation by Thieno[2,3-d]pyrimidin-4(1H)-one-based Analogues.

Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs

Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.

Parallel Synthesis and Biological Evaluation of 5,6,7,8‐tetrahydrobenzothieno[2,3‐d]pyrimidin‐4(3h)‐one Cytotoxic Agents Selective for P21‐deficient Cells.

Synthesis And Anti-Tumor Activity Of 4-(Methoxyl Thienyl)-3-(Substituted Benzoyl) Pyrroles

Synthesis and Anti-Tumor Activity of 1,4-Dihydrothieno[3',2':5,6]Thiopyrano[4,3-c]pyrazole-3-carboxylic Amide Derivatives

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

3-Aryl Β-Carbolin-1-ones As a New Class of Potent Inhibitors of Tumor Cell Proliferation: Synthesis and Biological Evaluation

Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents

Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy

Synthesis and Evaluation of Biological Activities of Thieno-[2,3- d ]-pyrimidine Derivatives

Antitumor Activity Of A 5-Hydroxy-1h-Pyrrol-2-(5h)-One-Based Synthetic Small Molecule In Vitro And In Vivo

Synthesis and Antitumor Activity of a Novel Series of 6-Substituted Pyrrolo[2,3-D]pyrimidines As Potential Nonclassical Antifolates Targeting Both Thymidylate and Purine Nucleotide Biosynthesis.

Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies

Synthesis, photophysical properties, anticancer evaluation, and molecular docking studies of new pyrimidine linked 4‐arylidene‐thiazolidin‐4‐ones as potent anticancer agents

Synthesis and in vitro cytotoxic evaluation of novel N -(3,4,5-trimethoxyphenyl)pyridin-2( 1H )-one derivatives

Identification of Thiazolo[5,4-D]pyrimidine Derivatives As Potent Antiproliferative Agents Through the Drug Repurposing Strategy

Rational synthesis and evaluation of 2,4-diamino-thieno[2,3-d]pyrimidines as antitumor agents

Discovery of new thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives as orally active phosphoinositide 3-kinase inhibitors